These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6143176)

  • 1. Strongyloidiasis and impaired immunity.
    Gill GV; Bell DR
    Lancet; 1984 Apr; 1(8381):858. PubMed ID: 6143176
    [No Abstract]   [Full Text] [Related]  

  • 2. Experiments on adoptive transfer of immunological tolerance and of immunity to Nippostrongylus brasiliensis in rats.
    Kassai T; Szepes G
    Acta Vet Acad Sci Hung; 1970; 20(2):207-17. PubMed ID: 5474489
    [No Abstract]   [Full Text] [Related]  

  • 3. Lack of immunoglobulin E response to longstanding strongyloidiasis.
    Gill GV; Bell DR; Fifield R
    Clin Exp Immunol; 1979 Aug; 37(2):292-4. PubMed ID: 498586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Initial results in Strongyloides stercoralis infestation of mice treated with cyclophosphamide].
    Mougeot G; Lancastre F
    Ann Parasitol Hum Comp; 1970; 45(5):591-6. PubMed ID: 5502995
    [No Abstract]   [Full Text] [Related]  

  • 5. Diminished immunological responsiveness to helminth parasites. The effect of repeated reinfection of rats from an early age with Nippostrongylus brasiliensis.
    Jarrett EE
    Clin Exp Immunol; 1971 Jan; 8(1):141-50. PubMed ID: 5540550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strongyloides stercoralis hyperinfection syndrome: how often is it missed?
    Cook GC
    Q J Med; 1987 Aug; 64(244):625-9. PubMed ID: 3328210
    [No Abstract]   [Full Text] [Related]  

  • 7. Duodenal immunoglobulins and cell-mediated immune response in human strongyloidiasis.
    Romia SA; Handoussa AE; Makhlouf LM; el-Malky SA
    J Egypt Soc Parasitol; 1988 Dec; 18(2):609-17. PubMed ID: 3418159
    [No Abstract]   [Full Text] [Related]  

  • 8. Fatal strongyloidiasis. In immunosuppressed patients.
    Cuni LJ; Rosner F; Chawla SK
    N Y State J Med; 1977 Nov; 77(13):2109-13. PubMed ID: 270629
    [No Abstract]   [Full Text] [Related]  

  • 9. [Massive strongyloidiasis. Apropos of 4 cases].
    Ramos MC; Pedro RJ; Silva LJ; Branchinni ML; Gonçales Júnior FL
    Rev Inst Med Trop Sao Paulo; 1984; 26(4):218-21. PubMed ID: 6522953
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunological features in different clinical forms of strongyloidiasis.
    Carvalho EM; Andrade TM; Andrade JA; Rocha H
    Trans R Soc Trop Med Hyg; 1983; 77(3):346-9. PubMed ID: 6623593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parasite-specific humoral responses in different clinical forms of strongyloidiasis.
    Badaró R; Carvalho EM; Santos RB; Gam AA; Genta RM
    Trans R Soc Trop Med Hyg; 1987; 81(1):149-50. PubMed ID: 3445303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfer of immunity against Strongyloides ratti (Nematoda) using immune spleen cells.
    Haddow WJ; Moqbel R; Wakelin D
    J Parasitol; 1984 Feb; 70(1):187-9. PubMed ID: 6737167
    [No Abstract]   [Full Text] [Related]  

  • 13. [Strongyloidiasis of the rabbit: trials of active immunization with x-irradiated filariform larvae of Strongyloides papillosus].
    Geyer E
    Z Parasitenkd; 1969; 33(2):164-76. PubMed ID: 5372769
    [No Abstract]   [Full Text] [Related]  

  • 14. [Host reactivity and resistance to Strongyloides stercoralis infection].
    Drăghici O; Drăghici G
    Microbiol Parazitol Epidemiol (Bucur); 1973; 18(1):43-8. PubMed ID: 4732972
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes in the metabolism of Nippostrongylus brasiliensis associated with the development of host immunity.
    Henney RW; Maclean IM; Mulligan W
    J Physiol; 1971; 217 Suppl():57P-58P. PubMed ID: 5124053
    [No Abstract]   [Full Text] [Related]  

  • 16. Prominence of IgG4 antibodies in the human responses to Strongyloides stercoralis infection.
    Genta RM; Lillibridge JP
    J Infect Dis; 1989 Oct; 160(4):692-9. PubMed ID: 2794561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strongyloides stercoralis and the immune response.
    Iriemenam NC; Sanyaolu AO; Oyibo WA; Fagbenro-Beyioku AF
    Parasitol Int; 2010 Mar; 59(1):9-14. PubMed ID: 19892034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific allergic sensitization to Strongyloides antigens in human strongyloidiasis.
    Genta RM; Ottesen EA; Poindexter R; Gam AA; Neva FA; Tanowitz HB; Wittner M
    Lab Invest; 1983 May; 48(5):633-8. PubMed ID: 6188884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strongyloidiasis in an HIV-1-infected patient after highly active antiretroviral therapy-induced immune restoration.
    Lanzafame M; Faggian F; Lattuada E; Antolini D; Vento S
    J Infect Dis; 2005 Mar; 191(6):1027. PubMed ID: 15717283
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunocompromised group differences in the presentation of intestinal strongyloidiasis.
    Vaiyavatjamai P; Boitano JJ; Techasintana P; Tungtrongchitr A
    Jpn J Infect Dis; 2008 Jan; 61(1):5-8. PubMed ID: 18219126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.